Dr. John Cush ✓

@RheumNow · Dallas, TX · joined 08 Apr 2011

Know-it-Now. Info on RA, Stills disease, Lupus, Gout, Pregnancy, Spondylitis, Psoriasis, Drug Safety, Rheumatology Research, Medical Education & Drug Evaluation

25 703Followers

450Following

35 442Posts total

2.9KViews on collected posts

Neueste Beiträge

Dr. John Cush ✓@RheumNow19 Sep

Join us for Tuesday Nite Rheumatology on September 22 for: Obesity Treatment & Safety Experts will tackle: • GLP-1/GIP therapies • Lifestyle & bariatric interventions • Treatment selection & safety • Cost & compounding concerns • Sarcopenia & bone health • The future of https://t

290 views · 2 likes · 2 reposts · 0 replies Open on X →

Dr. John Cush ✓@RheumNow18 Sep

🚨NEW FROM EULAR: In biologic-naive PsA, how do IL-23i, TNFi, and IL-17i compare on joint outcomes? 🦴Real-world data on TJC/SJC now available. Sponsored by AbbVie Medical Affairs + Health Impact. https://t.co/MG730IkB2w https://t.co/IAz2UaD2Eg

359 views · 1 likes · 0 reposts · 0 replies Open on X →

Dr. John Cush ✓@RheumNow18 Sep

Review of HLA-B27 What’s New? HLA-B27 remains the dominant genetic link to spondyloarthritis (SpA) across the age spectrum, but B27 related clinical expression diverges between children and adults. New mechanistic data on autoreactive T cells, HLA-B27 misfolding, and gut-joint

698 views · 18 likes · 8 reposts · 0 replies Open on X →

Dr. John Cush ✓@RheumNow18 Sep

Added IVIG is Effective in Myositis A small randomized controlled trial demonstrates that intravenous immunoglobulin (IVIG) added to cortocosteroids lead to greater and faster improvements in patients with newly diagnosed idiopathic inflammatory myopathies (IIMs). https://t.co/

623 views · 9 likes · 4 reposts · 0 replies Open on X →

Dr. John Cush ✓@RheumNow15 Sep

Obesity & Inflammation https://t.co/zmZe9YJFvx 880 views · 6 likes · 2 reposts · 0 replies Open on X →

Im Vergleich zu Konten gleicher Größe

5 Beiträge aus den letzten 90 Tagen, verglichen mit der Größenklasse 10K–100K Follower. erreicht weniger Menschen als Konten gleicher Größe.

Medianaufrufe623dieses Konto1 020Median für 10K–100K

Reichweite, %2.42%dieses Konto4.00%Median für 10K–100K

Interaktion, %1.38%dieses Konto1.55%Median für 10K–100K

Kennzahl	Dieses Konto	Median für 10K–100K	Verhältnis
Medianaufrufe pro Beitrag	623	1 020	0.61×
Reichweite (Aufrufe ÷ Follower)	2.42%	4.00%	0.61×
Interaktionsrate	1.38%	1.55%	0.89×

Weitere Konten dieser Größe → Mit einem anderen Konto vergleichen → Wie diese Vergleichswerte entstehen →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

88015 Sep

62318 Sep

698

359

29019 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.02%15 Sep

2.09%18 Sep

3.87%

0.28%

1.38%19 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.55%.

What the audience does

Likes53.7%36 in total

Reposts23.9%16 in total

Quotes3.0%2 in total

Bookmarks19.4%13 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Neueste Beiträge

Im Vergleich zu Konten gleicher Größe

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Ähnliche Konten